Early-stage medical Target E-merge Capital Partners as a potential buyer or advisor for early-stage medical device startups, leveraging their focus on class II cardiovascular and orthopedic devices and proximity to de-risked pathways for faster exits.

Operational partnership Highlight opportunities to engage through their Evolve Medtech Venture Studio partnership, offering hands-on development, design support, and potential co-innovation programs that can shorten product timelines and improve exit prospects.

De-risking criteria Position solutions that align with their stringent de-risking criteria, such as regulatory strategy clarification, clinical validation plans, and scalable manufacturing readiness, to increase fit for investment and collaboration.

Strategic exits Emphasize capabilities to map premaket submission pathways and exit timing, presenting services that accelerate regulatory milestones and market readiness to maximize LP returns.

Portfolio fit Offer targeted outreach to startups in underserved medical device markets or adjacent regulatory classes, providing a clear value proposition for investment, operational support, and potential co-funding opportunities.